Interpharm Holdings IncOver The Counter Market:IPAH
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Interpharm Holdings Inc | 670.0 | 0.0x | --- |
Praxsyn Corp | 790.0 | 0.0x | --- |
China Medicine Corp | 72.4K | 0.0x | --- |
Journey Medical Corp | 15.3M | -0.5x | --- |
Kali Inc | 1.0K | 0.0x | --- |
Integrated Biopharma Inc | 11.1M | 5.3x | +3.74% |
Company Information
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. During the fiscal year ended June 30, 2007 (fiscal 2007), the Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
Contact Information
- Headquarters
- 75 Adams AveHAUPPAUGE, NY, United States 11788-3605
- Phone
- 631-952-0214
- Fax
- 914-949-9618
Executives
- Chairman of the Board
- Maganlal Sutaria
- Chief Financial Officer, Chief Operating Officer, Executive Vice President
- Peter Giallorenzo
- Executive Vice President, General Counsel
- Kenneth Cappel
- Executive Vice President - Sales and Marketing
- Jeffrey Weiss
- Executive Vice President
- Raj Sutaria
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $670.00 |
|---|---|
Revenue (TTM) | $69.2M |
Shares Outstanding | 66.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.51 |
Book Value | $0.42 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -28.49% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
